Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2

Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2

Repurposing clinically available drugs to treat the new coronavirus disease 2019 (COVID-19) is an urgent need in the course of the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) pandemic, as very few treatment options are available. The iminosugar Miglustat is a well-characterized drug f...

Full description

Bibliographic Details
Main Authors: Sreejith Rajasekharan, Rafaela Milan Bonotto, Lais Nascimento Alves, Yvette Kazungu, Monica Poggianella, Pamela Martinez-Orellana, Natasa Skoko, Sulena Polez, Alessandro Marcello
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Viruses
Subjects:
COVID-19
SARS-CoV-2
coronavirus
inhibitor
antiviral
Miglustat
Online Access:https://www.mdpi.com/1999-4915/13/5/808

Internet

https://www.mdpi.com/1999-4915/13/5/808

Similar Items